United States Oral Vaccine Market Report 2017

August 2017 | 106 pages | ID: U4BEBE9097BEN
QYResearch

Abstracts

In this report, the United States Oral Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Oral Vaccine in these regions, from 2012 to 2022 (forecast).

United States Oral Vaccine market competition by top manufacturers/players, with Oral Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• ALK - Abello A/S (Denmark)
• Altimmune, Inc. (US)
• Bavarian Nordic A/S (Denmark)
• BiondVax Pharmaceuticals Ltd. (Israel)
• Bharat Biotech International Limited (India)
• GlaxoSmithKline Plc. (UK)
• Hualan Biological Engineering Inc. (China)
• Janssen Pharmaceuticals, Inc. (US)
• MedImmune (US)
• Merck & Co., Inc. (US)
• Pfizer Inc. (US)
• Sanofi Pasteur SA (France)
• Serum Institute of India Pvt. Ltd. (India)
• Shanghai BravoBio Co., Ltd. (China)
• Seqirus (UK)
• SK Chemicals Co., Ltd. (Korea)
• Takeda Pharmaceutical Company Limited (Japan)
• Zydus Cadila (India)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Young Infants
• Older Age Groups

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Vaccine for each application, including

• Disease Prevention
• Disease Treatment
• Others

Contents

United States Oral Vaccine Market Report 2017

1 ORAL VACCINE OVERVIEW

1.1 Product Overview and Scope of Oral Vaccine
1.2 Classification of Oral Vaccine by Product Category
  1.2.1 United States Oral Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Oral Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Young Infants
  1.2.4 Older Age Groups
1.3 United States Oral Vaccine Market by Application/End Users
  1.3.1 United States Oral Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Disease Prevention
  1.3.3 Disease Treatment
  1.3.4 Others
1.4 United States Oral Vaccine Market by Region
  1.4.1 United States Oral Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Oral Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Oral Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Oral Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Oral Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Oral Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Oral Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Vaccine (2012-2022)
  1.5.1 United States Oral Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Oral Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES ORAL VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oral Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Vaccine Market Competitive Situation and Trends
  2.4.1 United States Oral Vaccine Market Concentration Rate
  2.4.2 United States Oral Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ORAL VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Oral Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Oral Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Vaccine Price by Region (2012-2017)

4 UNITED STATES ORAL VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Oral Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Vaccine Price by Type (2012-2017)
4.4 United States Oral Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ORAL VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oral Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Oral Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ORAL VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 ALK - Abello A/S (Denmark)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ALK - Abello A/S (Denmark) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Altimmune, Inc. (US)
  6.2.2 Oral Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Altimmune, Inc. (US) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bavarian Nordic A/S (Denmark)
  6.3.2 Oral Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bavarian Nordic A/S (Denmark) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 BiondVax Pharmaceuticals Ltd. (Israel)
  6.4.2 Oral Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bharat Biotech International Limited (India)
  6.5.2 Oral Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bharat Biotech International Limited (India) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline Plc. (UK)
  6.6.2 Oral Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Plc. (UK) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Hualan Biological Engineering Inc. (China)
  6.7.2 Oral Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hualan Biological Engineering Inc. (China) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Janssen Pharmaceuticals, Inc. (US)
  6.8.2 Oral Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Janssen Pharmaceuticals, Inc. (US) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 MedImmune (US)
  6.9.2 Oral Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 MedImmune (US) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merck & Co., Inc. (US)
  6.10.2 Oral Vaccine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck & Co., Inc. (US) Oral Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Pfizer Inc. (US)
6.12 Sanofi Pasteur SA (France)
6.13 Serum Institute of India Pvt. Ltd. (India)
6.14 Shanghai BravoBio Co., Ltd. (China)
6.15 Seqirus (UK)
6.16 SK Chemicals Co., Ltd. (Korea)
6.17 Takeda Pharmaceutical Company Limited (Japan)
6.18 Zydus Cadila (India)

7 ORAL VACCINE MANUFACTURING COST ANALYSIS

7.1 Oral Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ORAL VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Oral Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Vaccine
Figure United States Oral Vaccine Market Size (K Units) by Type (2012-2022)
Figure United States Oral Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Young Infants Product Picture
Figure Older Age Groups Product Picture
Figure United States Oral Vaccine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Oral Vaccine by Application in 2016
Figure Disease Prevention Examples
Figure Disease Treatment Examples
Figure Others Examples
Figure United States Oral Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Vaccine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Oral Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Vaccine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Oral Vaccine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Oral Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Oral Vaccine Sales Share by Players/Suppliers
Figure United States Oral Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Oral Vaccine Revenue Share by Players/Suppliers
Table United States Market Oral Vaccine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Vaccine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Oral Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Oral Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Vaccine Product Category
Table United States Oral Vaccine Sales (K Units) by Region (2012-2017)
Table United States Oral Vaccine Sales Share by Region (2012-2017)
Figure United States Oral Vaccine Sales Share by Region (2012-2017)
Figure United States Oral Vaccine Sales Market Share by Region in 2016
Table United States Oral Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Vaccine Revenue Share by Region (2012-2017)
Figure United States Oral Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Oral Vaccine Revenue Market Share by Region in 2016
Table United States Oral Vaccine Price (USD/Unit) by Region (2012-2017)
Table United States Oral Vaccine Sales (K Units) by Type (2012-2017)
Table United States Oral Vaccine Sales Share by Type (2012-2017)
Figure United States Oral Vaccine Sales Share by Type (2012-2017)
Figure United States Oral Vaccine Sales Market Share by Type in 2016
Table United States Oral Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccine by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccine by Type in 2016
Table United States Oral Vaccine Price (USD/Unit) by Types (2012-2017)
Figure United States Oral Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Oral Vaccine Sales (K Units) by Application (2012-2017)
Table United States Oral Vaccine Sales Market Share by Application (2012-2017)
Figure United States Oral Vaccine Sales Market Share by Application (2012-2017)
Figure United States Oral Vaccine Sales Market Share by Application in 2016
Table United States Oral Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Oral Vaccine Sales Growth Rate by Application (2012-2017)
Table ALK - Abello A/S (Denmark) Basic Information List
Table ALK - Abello A/S (Denmark) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ALK - Abello A/S (Denmark) Oral Vaccine Sales Growth Rate (2012-2017)
Figure ALK - Abello A/S (Denmark) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure ALK - Abello A/S (Denmark) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Altimmune, Inc. (US) Basic Information List
Table Altimmune, Inc. (US) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Altimmune, Inc. (US) Oral Vaccine Sales Growth Rate (2012-2017)
Figure Altimmune, Inc. (US) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure Altimmune, Inc. (US) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Bavarian Nordic A/S (Denmark) Basic Information List
Table Bavarian Nordic A/S (Denmark) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S (Denmark) Oral Vaccine Sales Growth Rate (2012-2017)
Figure Bavarian Nordic A/S (Denmark) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure Bavarian Nordic A/S (Denmark) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List
Table BiondVax Pharmaceuticals Ltd. (Israel) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Oral Vaccine Sales Growth Rate (2012-2017)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Bharat Biotech International Limited (India) Basic Information List
Table Bharat Biotech International Limited (India) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bharat Biotech International Limited (India) Oral Vaccine Sales Growth Rate (2012-2017)
Figure Bharat Biotech International Limited (India) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure Bharat Biotech International Limited (India) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. (UK) Oral Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc. (UK) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc. (UK) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Hualan Biological Engineering Inc. (China) Basic Information List
Table Hualan Biological Engineering Inc. (China) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Inc. (China) Oral Vaccine Sales Growth Rate (2012-2017)
Figure Hualan Biological Engineering Inc. (China) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure Hualan Biological Engineering Inc. (China) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information List
Table Janssen Pharmaceuticals, Inc. (US) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals, Inc. (US) Oral Vaccine Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals, Inc. (US) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceuticals, Inc. (US) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table MedImmune (US) Basic Information List
Table MedImmune (US) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MedImmune (US) Oral Vaccine Sales Growth Rate (2012-2017)
Figure MedImmune (US) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure MedImmune (US) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. (US) Oral Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. (US) Oral Vaccine Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. (US) Oral Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Inc. (US) Basic Information List
Table Sanofi Pasteur SA (France) Basic Information List
Table Serum Institute of India Pvt. Ltd. (India) Basic Information List
Table Shanghai BravoBio Co., Ltd. (China) Basic Information List
Table Seqirus (UK) Basic Information List
Table SK Chemicals Co., Ltd. (Korea) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Zydus Cadila (India) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccine
Figure Manufacturing Process Analysis of Oral Vaccine
Figure Oral Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Oral Vaccine
Table Distributors/Traders List
Figure United States Oral Vaccine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Oral Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Oral Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oral Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oral Vaccine Sales Volume (K Units) Forecast by Type in 2022
Table United States Oral Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oral Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oral Vaccine Sales Volume (K Units) Forecast by Application in 2022
Table United States Oral Vaccine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Oral Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources